本页面由Tiger Trade Technology Pte. Ltd.提供服务

Taysha Gene Therapies, Inc.

4.44
-0.0550-1.22%
成交量:117.38万
成交额:520.52万
市值:12.15亿
市盈率:-13.20
高:4.54
开:4.38
低:4.30
收:4.49
52周最高:6.02
52周最低:1.05
股本:2.74亿
流通股本:1.84亿
量比:0.65
换手率:0.64%
股息:- -
股息率:- -
每股收益(TTM):-0.3359
每股收益(LYR):-0.3570
净资产收益率:-64.93%
总资产收益率:-25.70%
市净率:5.55
市盈率(LYR):-12.42

数据加载中...

2026/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/06

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/11/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/04

重要事件披露

Form 8-K - Current report
2025/11/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/17

重要事件披露

Form 8-K - Current report
2025/10/09

重要事件披露

Form 8-K - Current report